Next Article in Journal
Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
Next Article in Special Issue
Trends in the Prescription of Strong Opioids for Chronic Non-Cancer Pain in Primary Care in Catalonia: Opicat-Padris-Project
Previous Article in Journal
The Impact of Fullerenes as Doxorubicin Nano-Transporters on Metallothionein and Superoxide Dismutase Status in MCF-10A Cells
Previous Article in Special Issue
Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 103; https://doi.org/10.3390/pharmaceutics14010103
Action Date Notes Link
article xml file uploaded 2 January 2022 12:31 CET Original file -
article xml uploaded. 2 January 2022 12:31 CET Update -
article pdf uploaded. 2 January 2022 12:31 CET Version of Record https://www.mdpi.com/1999-4923/14/1/103/pdf-vor
article html file updated 2 January 2022 12:32 CET Original file -
article xml file uploaded 5 January 2022 11:31 CET Update -
article xml uploaded. 5 January 2022 11:31 CET Update https://www.mdpi.com/1999-4923/14/1/103/xml
article pdf uploaded. 5 January 2022 11:32 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/103/pdf
article html file updated 5 January 2022 11:34 CET Update -
article html file updated 31 July 2022 01:46 CEST Update https://www.mdpi.com/1999-4923/14/1/103/html
Back to TopTop